Precision approaches
Location: Plenary 3
Back to listThe genomic and pathological features of BRCA2 - mutant prostate cancer
- Time:
- 1:30 PM - 1:50 PM
- Speakers:
Dr Mitch Lawrence
Unusual subtypes of prostate cancer: Critical Information for the urologist
- Time:
- 1:50 PM - 2:10 PM
- Speakers:
Dr Jonathan Epstein
Prostate Cancer heterogeneity
- Time:
- 2:10 PM - 2:30 PM
- Speakers:
Dr Cora Sternberg
What are the reasonable indications for an integrated focal therapy programme within a high quality uro-oncology service
- Time:
- 2:30 PM - 2:45 PM
- Speakers:
Prof Mark Emberton
Discussion
- Time:
- 2:45 PM - 3:00 PM
- Speakers:
Panel Discussion